Ann Lab Med.  2023 Nov;43(6):635-637. 10.3343/alm.2023.43.6.635.

ABO Blood Group Antigen Changes in Acute Myeloid Leukemia and No Significant Association With RUNX1 and GATA2 Somatic Variants

• Jeong IH
• Seo JY
• Choi S
• Kim HY
• Cho D

• KMID: 2552044
• DOI: http://doi.org/10.3343/alm.2023.43.6.635

Reference

1. Schenkel-Brunner H. 2000. Human blood groups. Springer;Wien:

2. Daniels G. 2013. Human blood groups. Wiley-Blackwell;West Sussex:

3. Kominato Y, Sano R, Takahashi Y, Hayakawa A, Ogasawara K. 2020; Human ABO gene transcriptional regulation. Transfusion. 60:860–9. DOI: 10.1111/trf.15760. PMID: 32216153. PMCID: PMC7187371.

4. Hayakawa A, Sano R, Takahashi Y, Okawa T, Kubo R, Harada M, et al. 2022; Reduction of blood group A antigen on erythrocytes in a patient with myelodysplastic syndrome harboring somatic mutations in RUNX1 and GATA2. Transfusion. 62:469–80. DOI: 10.1111/trf.16766. PMID: 34918362.

5. Hayakawa A, Sano R, Takahashi Y, Kubo R, Harada M, Omata M, et al. 2020; RUNX1 mutation in a patient with myelodysplastic syndrome and decreased erythrocyte expression of blood group A antigen. Transfusion. 60:184–96. DOI: 10.1111/trf.15628. PMID: 31840280.

6. Choi SY, Kim SI, Cho HI. 1984; Study on gene frequencies of blood groups in Koreans. Korean J Hematol. 19:63–75.

7. Orlow I, Lacombe L, Pellicer I, Rabbani F, Delgado R, Zhang ZF, et al. 1998; Genotypic and phenotypic characterization of the histoblood group ABO(H) in primary bladder tumors. Int J Cancer. 75:819–24. DOI: 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y.

8. Iwamoto S, Withers DA, Handa K, Hakomori S. 1999; Deletion of A-antigen in a human cancer cell line is associated with reduced promoter activity of CBF/NF-Y binding region, and possibly with enhanced DNA methylation of A transferase promoter. Glycoconj J. 16:659–66. DOI: 10.1023/A:1007085202379. PMID: 10972144.

9. Kominato Y, Hata Y, Takizawa H, Tsuchiya T, Tsukada J, Yamamoto F. 1999; Expression of human histo-blood group ABO genes is dependent upon DNA methylation of the promoter region. J Biol Chem. 274:37240–50. DOI: 10.1074/jbc.274.52.37240. PMID: 10601288.

10. Li MM, Datto M, Duncavage EJ, Kulkarni S, Lindeman NI, Roy S, et al. 2017; Standards and guidelines for the interpretation and reporting of sequence variants in cancer: a joint consensus recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists. J Mol Diagn. 19:4–23. DOI: 10.1016/j.jmoldx.2016.10.002. PMID: 27993330. PMCID: PMC5707196.